Pharma Industry Has A New Drug: Artificial Intelligence

It's almost difficult to talk about the future of any industry without referencing artificial intelligence (AI). Increasingly, pharma and biotech organizations are embracing more effective, automated processes that integrate data-driven decisions and utilize predictive analytics tools. The next development of this approach to deal with cutting-edge data analytics fuses machine learning and AI. The absolute most discussed issues incorporate drug deficiencies, clinical trials, and the opioid epidemic, all within the difficulties of the COVID-19 pandemic. Despite the fact that these issues appear to be inauspicious and huge, AI is deliberately positioned to help us better address all challenges.